n-formylmethionine leucyl-phenylalanine has been researched along with cefodizime in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anjo, S; Arai, T; Ishibashi, Y; Osaki, E | 1 |
| Bialasiewicz, P; Dutkiewicz, B; Mikucki, J; Nowak, D; Piasecka, G; Stolarek, R; Wejner, P | 1 |
2 other study(ies) available for n-formylmethionine leucyl-phenylalanine and cefodizime
| Article | Year |
|---|---|
Cefodizime enhances formyl-methionyl-leucyl-phenylalanine-induced hydrogen peroxide production from human neutrophils.
Topics: Cefotaxime; Drug Synergism; Humans; Hydrogen Peroxide; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Tetradecanoylphorbol Acetate | 1993 |
Cefodizime enhances phagocytosis and intracellular killing of Staphylococcus aureus but does not influence polymorphonuclear leukocytes response to fMLP stimulation.
Topics: Adjuvants, Immunologic; Adult; Anti-Bacterial Agents; Calcium; Cefotaxime; Cell Degranulation; Female; Humans; Hydrogen Peroxide; Intracellular Fluid; Luminescent Measurements; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phagocytosis; Staphylococcus aureus | 2000 |